Patents by Inventor David Kylhammar

David Kylhammar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating pulmonary hypertension
    Patent number: 11141422
    Abstract: The present invention relates to methods for treating or preventing pulmonary hypertension, reducing mortality in a subject experiencing pulmonary hypertension, or inhibiting ADP-mediated vasoconstriction of pulmonary arteries in a subject, comprising administering to the subject an effective amount of a pharmaceutical composition comprising a reversible P2Y12 receptor antagonist. Also provided are related medicaments, pharmaceutical compositions, and methods for preparing the medicaments.
    Type: Grant
    Filed: April 4, 2019
    Date of Patent: October 12, 2021
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: David Kylhammar, Goran Radegran
  • METHODS FOR TREATING PULMONARY HYPERTENSION
    Publication number: 20190298753
    Abstract: The present invention relates to methods for treating or preventing pulmonary hypertension, reducing mortality in a subject experiencing pulmonary hypertension, or inhibiting ADP-mediated vasoconstriction of pulmonary arteries in a subject, comprising administering to the subject an effective amount of a pharmaceutical composition comprising a reversible P2Y12 receptor antagonist. Also provided are related medicaments, pharmaceutical compositions, and methods for preparing the medicaments.
    Type: Application
    Filed: April 4, 2019
    Publication date: October 3, 2019
    Inventors: David Kylhammar, Goran Radegran
  • Methods for treating pulmonary hypertension
    Patent number: 10300084
    Abstract: The present invention relates to methods for treating or preventing pulmonary hypertension, reducing mortality in a subject experiencing pulmonary hypertension, or inhibiting ADP-mediated vasoconstriction of pulmonary arteries in a subject, comprising administering to the subject an effective amount of a pharmaceutical composition comprising a reversible P2Y12 receptor antagonist. Also provided are related medicaments, pharmaceutical compositions, and methods for preparing the medicaments.
    Type: Grant
    Filed: January 22, 2016
    Date of Patent: May 28, 2019
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: David Kylhammar, Goran Radegran
  • Methods for Treating Pulmonary Hypertension
    Publication number: 20160136196
    Abstract: The present invention relates to methods for treating or preventing pulmonary hypertension, reducing mortality in a subject experiencing pulmonary hypertension, or inhibiting ADP-mediated vasoconstriction of pulmonary arteries in a subject, comprising administering to the subject an effective amount of a pharmaceutical composition comprising a reversible P2Y12 receptor antagonist. Also provided are related medicaments, pharmaceutical compositions, and methods for preparing the medicaments.
    Type: Application
    Filed: January 22, 2016
    Publication date: May 19, 2016
    Inventors: David Kylhammar, Goran Radegran
  • Methods for Treating Pulmonary Hypertension
    Publication number: 20140073590
    Abstract: The present invention relates to methods for treating or preventing pulmonary hypertension, reducing mortality in a subject experiencing pulmonary hypertension, or inhibiting ADP-mediated vasoconstriction of pulmonary arteries in a subject, comprising administering to the subject an effective amount of a pharmaceutical composition comprising a reversible P2Y12 receptor antagonist. Also provided are related medicaments, pharmaceutical compositions, and methods for preparing the medicaments.
    Type: Application
    Filed: August 9, 2013
    Publication date: March 13, 2014
    Applicant: The Medicines Company
    Inventors: David Kylhammar, Goran Radegran